Abstract
Although a high incidence of occurrence of lung carcinoma is observed nowadays, the increase of survival rate is as low as before. The principal therapy for lung carcinoma has been surgical resection, but in addition to this method, we are using now various types of neoplastic agents for adjuvant combination therapy. In this paper, clinical data of resected lung carcinoma patients in our unit are analyzed, and the role of surgery and chemotherapy for advanced stages is discussed.
